NASDAQ:PETS PetMed Express (PETS) Stock Price, News & Analysis $0.90 -0.04 (-4.52%) Closing price 04:00 PM EasternExtended Trading$0.91 +0.01 (+1.48%) As of 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC Filings About PetMed Express Stock (NASDAQ:PETS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get PetMed Express alerts:Sign Up Key Stats Today's Range$0.85▼$0.9550-Day Range$0.90▼$1.7652-Week Range$0.85▼$4.10Volume220,579 shsAverage Volume115,469 shsMarket Capitalization$19.96 millionP/E RatioN/ADividend YieldN/APrice Target$1.40Consensus RatingStrong Sell Company Overview PetMed Express, also known as 1-800-PetMeds, is an online pet pharmacy that sells prescription and nonprescription medications and health products for dogs, cats and other companion animals. Customers can shop through its website or by phone. Its offerings include medications for conditions such as heartworm, flea and tick infestations, allergies and chronic illnesses, as well as pet food, vitamins and supplements. For prescription products, the company works with veterinarians to verify prescriptions. Founded in 1996, PetMed Express serves customers in the United States. Its business focuses on providing pet owners with access to medications and other animal-care products through direct-to-consumer channels.AI Generated. May Contain Errors. Read More PetMed Express Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks52nd Percentile Overall ScorePETS MarketRank™: 2.604635761585 of 5 starsPetMed Express scored higher than 52% of companies evaluated by MarketBeat, and ranked 296th out of 472 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.1 / 5Analyst RatingStrong Sell Consensus RatingPetMed Express has received a consensus rating of Strong Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 3 sell ratings.Upside PotentialPetMed Express has a consensus price target of $1.40, representing about 56.0% upside from its current price of $0.90.Amount of Analyst CoveragePetMed Express has only been the subject of 3 research reports in the past 90 days.Read more about PetMed Express' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for PetMed Express are expected to grow in the coming year, from ($0.50) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about PetMed Express' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.88% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 9.12.Change versus previous monthShort interest in PetMed Express has recently decreased by 7.44%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthWeak Dividend YieldPetMed Express does not currently pay a dividend.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Read more about PetMed Express' dividend. News and Social Media1.7 / 5News Sentiment-0.24 News SentimentPetMed Express has a news sentiment score of -0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.53 average news sentiment score of Consumer Discretionary companies.News Coverage This WeekMarketBeat has tracked 6 news articles for PetMed Express this week, compared to 2 articles on an average week.Search Interest7 people have searched for PETS on MarketBeat in the last 30 days. This is an increase of 250% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by Insiders1.30% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions73.33% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about PetMed Express' insider trading history. Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PETS Stock News HeadlinesPetMed Express, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026November 12, 2026 | marketscreener.comMPetMeds outlines turnaround plan as customer acquisition cost falls 32% to $51November 10, 2026 | seekingalpha.comYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on Elon Musk's next big industry play. He estimates it could create 1.8 million new millionaires in the coming years, and shows how to position in the company at its center for under $60. Inside: the company's name and ticker, plus an FCC filing James believes reveals Elon's plan to take over a $25 trillion industry. He also flags December 8 as a key date.November 16 at 1:00 AM | Paradigm Press (Ad)PetMed Express Q2 2027 Earnings Call TranscriptNovember 10, 2026 | benzinga.comPetMeds® Announces Second Quarter Financial ResultsNovember 10, 2026 | globenewswire.comPetMed Express Q2 earnings previewNovember 9, 2026 | msn.comPetMeds Announces Strategic Partnership with Pet Supermarket to Expand Pharmacy Offering Across Retail and Digital ChannelsNovember 9, 2026 | globenewswire.comPetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026October 27, 2026 | globenewswire.comSee More Headlines PETS Stock Analysis - Frequently Asked Questions How have PETS shares performed this year? PetMed Express' stock was trading at $3.20 at the beginning of 2026. Since then, PETS stock has decreased by 71.9% and is now trading at $0.8977. How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings results on Tuesday, November, 10th. The company reported ($0.31) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by $0.20. The business earned $35.77 million during the quarter, compared to analysts' expectations of $62 million. PetMed Express had a negative net margin of 16.97% and a negative trailing twelve-month return on equity of 107.14%. Read the conference call transcript. Who are PetMed Express' major shareholders? Top institutional shareholders of PetMed Express include State Street Corp (0.64%) and Empowered Funds LLC (0.47%). Insiders that own company stock include Silvercape Investments Ltd, Nina Capital Holdings Inc, Sandra Yvette Campos, Leslie CG Campbell and Jacqueline Paula Smith. View institutional ownership trends. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some other companies that PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), AT&T (T), Ford Motor (F), Pfizer (PFE) and Johnson & Johnson (JNJ). Company Calendar Last Earnings11/10/2026Today11/16/2026Next Earnings (Estimated)2/04/2027Fiscal Year End3/31/2027Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (7m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 PETS's financial health is in the Red zone, according to TradeSmith. PETS has been in this zone for over 7 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorConsumer Discretionary Industry Specialty Retail Sub-IndustryOther Specialty Retail Current SymbolNASDAQ:PETS CIK1040130 Webwww.petmeds.com Phone(561) 426-4444Fax561-526-4445Employees189Year Founded1996Price Target and Rating Average Price Target for PetMed Express$1.40 High Price Target$1.40 Low Price Target$1.40 Potential Upside/Downside+56.0%Consensus RatingStrong Sell Rating Score (0-4)1.00 Research Coverage3 Analysts Profitability EPS (Trailing Twelve Months)($1.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$57.29 million Net Margins-16.97% Pretax Margin-17.01% Return on Equity-107.14% Return on Assets-37.21% Debt Debt-to-Equity RatioN/A Current Ratio0.60 Quick Ratio0.45 Sales & Book Value Annual Sales$160.26 million Price / Sales0.12 Cash Flow$0.30 per share Price / Cash Flow3.04 Book Value$1.35 per share Price / Book0.66Miscellaneous Outstanding Shares22,231,000Free Float21,942,000Market Cap$19.96 million OptionableOptionable Beta0.82 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:PETS) was last updated on 11/16/2026 by MarketBeat.com Staff. From Our PartnersA $247 tool for $7Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full ...Profits Run | SponsoredWhy I'm selling my Snapback Indicator for just $7For Black Friday, Base Camp Trading's Thomas Wood is offering lifetime access to his proprietary Snapback Indi...Base Camp Trading | SponsoredWhat the hell is going on?Porter Stansberry says President Trump is quietly replacing the U.S. dollar without a vote in Congress, and th...Porter & Company | SponsoredYour Copy is on Hold (Claim it now)James Altucher, who called NVIDIA in 2008 and SpaceX years before a single share traded, has a new report on E...Paradigm Press | SponsoredEvery Starlink dish pays this stockThere's a chip inside every Tesla and Starlink dish that Elon doesn't own. He pays royalties to use it. Now...Behind the Markets | SponsoredDrop these 5 stocks before the market opens tomorrow!The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratin...Weiss Ratings | SponsoredSmall-Cap SMX is Taking its Technology into Multiple Trillion-Dollar Industries!SMX (NASDAQ: SMX) uses proprietary molecular-marking technology and a Digital Material Passport platform to gi...Smallcaps Daily | SponsoredThis Tech Could Be Bigger Than Apple, Amazon, and Microsoft CombinedA breakthrough technology backed by Elon Musk, Sam Altman and Jensen Huang could one day be worth more than Ap...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PetMed Express With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.